You are currently browsing:

Genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds

A genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, a Standford Medicine study finds. Conversely, these drugs could be avoided if it was known a patient was unlikely to benefit from their use. If you would like to read more about this study, click the link below: http://med.stanford.edu/news/all-news/2019/11/genetic-_fingerprint-may-id-breast-cancer-patients-likely-to-ben.html?fbclid=IwAR2WwjX6SzgZCBkIdO999FPMBM92bUuHyBbMhwWf5nySznZTw4DNqCUusK4

Read More

YOUR VOTE IS NEEDED

Breast Cancer Ireland is delighted to be shortlisted in the Permanent TSB Community Fund, an exciting new Community Programme that will see €100,000 distributed to five worthy charities across the country. To vote for Breast Cancer Ireland under ‘Region: South’, please click on the link below: https://www.permanenttsb.ie/responsible-bus…/community-fund/ Voting closes on Friday, December 20. Permanent TSB […]

Read More

Ballyagran Pink Nights raises almost €60,000 for Breast Cancer Ireland

Breast Cancer Ireland are incredibly grateful for the funds raised from this year’s Ballyagran Pink Ribbon Night which raised an amazing €16,305. Maura’s Pink Ribbon Nights have been running for over nine years and this year’s funds bring their total amount to €58,805. Thank you to all involved for your continued support.  

Read More

Precision Oncology Ireland

Launched on November 26, Precision Oncology Ireland is a consortium of five Irish universities, six Irish cancer charities and ten companies that collectively aim to develop new diagnostics and therapeutics for personalized cancer treatment. Breast Cancer Ireland is proud to be a part of 21 Partners – with 1 Vision – Personalized Medicine for Cancer. […]

Read More

Fighting fire with fire: How our immune systems can help fight breast cancer

Ever since the 2018 Nobel Prize for Medicine or Physiology was awarded to two pioneers (James P. Allison and Tasuku Honjo) of the emerging science of immunotherapy, scientific literature has been buzzing with new advancements in this field. So what is cancer immunotherapy, and what is its relevance to breast cancer? New treatments are seeking […]

Read More
X